Early response assessment in prostate carcinoma by 18F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models

Comparison of [18F]-Tracers in Various Experimental Tumor Models by PET Imaging and Identification of an Early Response Biomarker for the Novel Microtubule Stabilizer Patupilone

Usefulness of 3′-[F-18]Fluoro-3′-deoxythymidine with Positron Emission Tomography in Predicting Breast Cancer Response to Therapy

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.

Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate.

11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.

Epothilone B and its analogs - a new family of anticancer agents.

Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer.

3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules.

Early changes in [18F]FLT uptake after chemotherapy: an experimental study

Early response assessment in prostate carcinoma by 18F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models

An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography 18F-FLT PET/CT in Prostate Adenocarcinoma

Preclinical Applications of 3'-Deoxy-3'-[18F]Fluorothymidine in Oncology - A Systematic Review

PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer.

Imaging Cellular Proliferation in Prostate Cancer with Positron Emission Tomography

[18F]Fluoromethylcholine as a Chemotherapy Response Read-Out in Prostate Cancer Cells

Prospects in radionuclide imaging of prostate cancer.

Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3′-deoxy-3′-[18F]fluorothymidine in preclinical tumor models

Imaging, Diagnosis, Prognosis [18F]-30Deoxy-30-Fluorothymidine Positron Emission Tomography and Breast Cancer Response to Docetaxel

a pilot clinical study

Comparison of [18F]-Tracers in Various Experimental Tumor Models by PET Imaging and Identification of an Early Response Biomarker for the Novel Microtubule Stabilizer Patupilone

Usefulness of 3′-[F-18]Fluoro-3′-deoxythymidine with Positron Emission Tomography in Predicting Breast Cancer Response to Therapy

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.

Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate.

11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.

Epothilone B and its analogs - a new family of anticancer agents.

Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer.

3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules.

Early changes in [18F]FLT uptake after chemotherapy: an experimental study

Early response assessment in prostate carcinoma by 18F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models

An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography 18F-FLT PET/CT in Prostate Adenocarcinoma

Preclinical Applications of 3'-Deoxy-3'-[18F]Fluorothymidine in Oncology - A Systematic Review

PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer.

Imaging Cellular Proliferation in Prostate Cancer with Positron Emission Tomography

[18F]Fluoromethylcholine as a Chemotherapy Response Read-Out in Prostate Cancer Cells

Prospects in radionuclide imaging of prostate cancer.

Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3′-deoxy-3′-[18F]fluorothymidine in preclinical tumor models

Imaging, Diagnosis, Prognosis [18F]-30Deoxy-30-Fluorothymidine Positron Emission Tomography and Breast Cancer Response to Docetaxel

a pilot clinical study

Comparison of [18F]-Tracers in Various Experimental Tumor Models by PET Imaging and Identification of an Early Response Biomarker for the Novel Microtubule Stabilizer Patupilone

Usefulness of 3′-[F-18]Fluoro-3′-deoxythymidine with Positron Emission Tomography in Predicting Breast Cancer Response to Therapy

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.

Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate.

11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.

Epothilone B and its analogs - a new family of anticancer agents.

Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer.

3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules.

Early changes in [18F]FLT uptake after chemotherapy: an experimental study